Menopause

"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

The FDA has granted priority review to expand flibanserin (Addyi; Sprout Pharmaceuticals) use to postmenopausal women, potentially broadening access to treatment for hypoactive sexual desire disorder.

Experts urge the FDA to update outdated warnings on menopausal hormone therapies, emphasizing the safety and benefits of low-dose vaginal estrogen.

Nearly one-third of women with premature ovarian insufficiency experience depressive symptoms, according to a recent study.

Tirzepatide and menopause hormone therapy may significantly enhance weight loss and health outcomes in postmenopausal women.

A low-fat, soy-rich vegan diet significantly decreases severe hot flashes and supports healthy weight loss, according to new research.

A new study reveals that emotional symptoms such as anger and feeling out of control intensify before menstruation and become more severe during the menopause transition.

Women living in neighborhoods with very high social vulnerability are more likely to experience natural menopause at a younger age, according to new research.

In this Q&A, Karyn S. Eilber, MD, shares some of the biggest takeaways from the new AUA/SUFU/AUGS 2025 Guidelines on Genitourinary Syndrome of Menopause.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Angie Lee, MD, FACOG, discusses how clinicians can bridge the gap in menopause care to ensure better outcomes for their patients.

A meta-analysis presented at 2025 ACOG Annual Clinical & Scientific Meeting found that elinzanetant demonstrated a reduction in VMS frequency and intensity.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

New research reveals that maintaining healthy blood iron levels may improve cognitive performance and reduce brain fog in women during the menopausal transition.

New guidelines on GSM recommends symptom-based diagnosis, shared decision-making, and local estrogen as first-line therapy to improve quality of life.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study finds that women who experience menopause before the age of 40 years face a higher risk of cognitive decline.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Discover how fezolinetant (VEOZAH; Astellas Pharma) is helping women manage moderate to severe vasomotor symptoms of menopause with rapid and effective relief.

A new study finds that postmenopausal women with a reduced creatinine-to-cystatin C ratio experience decreased muscle volume and slower walking speed, highlighting its role as a potential biomarker for muscle health.

A new study highlights the connection between heavy or prolonged menstrual bleeding and increased fatigue in menopausal women, emphasizing the need for greater clinical awareness and early intervention.

A recent study shows that intentional weight loss significantly lowers all-cause, cancer, and cardiovascular mortality risks among postmenopausal women, highlighting the importance of targeted weight management.

A recent study from researchers at the University of Calgary found that a higher frequency of menopausal symptoms i linked to poorer cognitive function and behavioral impairments

Research suggests that hormone replacement therapy, especially with testosterone, may help alleviate mood symptoms in menopausal women and reduce the need for antidepressants.

Many women experience perimenopause symptoms in their 30s, but most delay treatment. Early awareness can improve care and quality of life.

A new study highlights adiponectin’s strong links to obesity and metabolic health markers, suggesting its potential as an effective tool for predicting and managing cardiometabolic risk in perimenopausal women.

A new study highlights the anti-aging properties of key hormones, offering potential treatments for wrinkles, hair graying, and other signs of aging.

A new study from the University of Colorado Boulder suggests that women who experience menopause at age 55 years or later may have significantly better vascular health and a reduced risk of heart attacks and strokes.

A new study found that menopausal hormone therapy is associated with a higher risk of systemic lupus erythematosus and systemic sclerosis, emphasizing the role of female sex hormones in immune-mediated diseases.